Sage Therapeutics (SAGE) Moves 35.1% Higher: Will This Strength Last?

Sage Therapeutics, Inc. (SAGE) shares soared 35.1% in the last trading session to close at $7.50. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.1% gain over the past four weeks.The stock rallied after the company announced that its partner Biogen had made an unsolicited, non-binding proposal offer to acquire SAGE shares that it does not already own for$ 7.22 per share. The offer price represented a premium of 30% on Sage Ther ...